WuXi Biologics
WXXWY----
H1 2026 Earnings
Financial report interval: 2025.12.30 - 2026.06.30
Overview: WuXi Biologics(WXXWY) the Revenue is 1.736 B (+24.95%), Beat estimate;the EBIT is 564.77 M (+41.56%), Beat estimate.
Actual
YoY
Estimate
YoY
Vs estimate
YoY
RevenueExceed expectations
1.74B24.95%
1.69B21.61%
+0.05B3.34%
EBITExceed expectations
0.56B41.56%
0.48B19.26%
+0.09B22.30%
Upcoming earnings report - Q3 FY2026
Available dateNov 25, 2026
Estimate Revenue--
Estimate EBIT--
Estimate EPS--
Revenue
ActualEstimateUnit: USD
Quarterly
EBIT
ActualEstimateUnit: USD
Quarterly
Net income
ActualEstimateUnit: USD
Quarterly
EPS
ActualEstimateUnit: USD
Quarterly